Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function

This study seeks to test our hypothesis that transgenic induction of miR-210 in mesenchymal stem cells (MSC) simulates the pro-survival effects of ischemic preconditioning (IPC) and that engraftment of PC MSC helps in the functional recovery of ischemic heart by miR-210 transfer to host cardiomyocyt...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of molecular medicine (Berlin, Germany) Germany), 2012-09, Vol.90 (9), p.997-1010
Hauptverfasser: Kim, Ha Won, Jiang, Shujia, Ashraf, Muhammad, Haider, Khawaja Husnain
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1010
container_issue 9
container_start_page 997
container_title Journal of molecular medicine (Berlin, Germany)
container_volume 90
creator Kim, Ha Won
Jiang, Shujia
Ashraf, Muhammad
Haider, Khawaja Husnain
description This study seeks to test our hypothesis that transgenic induction of miR-210 in mesenchymal stem cells (MSC) simulates the pro-survival effects of ischemic preconditioning (IPC) and that engraftment of PC MSC helps in the functional recovery of ischemic heart by miR-210 transfer to host cardiomyocytes through gap junctions. miR-210 expression in MSC was achieved by IPC or nanoparticle-based transfection of miR-210 plasmid ( miR MSC) and functional recovery of the infarcted heart of rat transplanted with PC MSC or miR MSC was evaluated. Both PC MSC and miR MSC showed higher survival under lethal anoxia as compared to non-PC MSC and scramble-transfected MSC ( Sc MSC) controls with concomitantly lower CASP8AP2 expression. Similarly, both PC MSC and miR MSC survived better and accelerated functional recovery of ischemic heart post-transplantation. To validate our hypothesis that MSC deliver miR-210 to host cardiomyocytes, in vitro co-culture between cardiomyocytes and PC MSC or miR MSC (using non-PC MSC or Sc MSC as controls) showed co-localization of miR-210 with gap-junctional connexin-43. miR-210 transfer to cardiomyocytes was blocked by heptanol pretreatment. Moreover, higher survival of cardiomyocytes co-cultured with PC MSC was observed with concomitant expression of CASP8AP2 as compared to cardiomyocytes co-cultured with non-PC MSC thus suggesting that miR-210 was translocated from MSC to protect host cardiomyocytes. Induction of miR-210 in MSC promoted their survival post-engraftment in the infarcted heart. Moreover, direct transfer of pro-survival miR-210 from miR MSC to host cardiomyocytes led to functional recovery of the ischemic heart.
doi_str_mv 10.1007/s00109-012-0920-1
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3423492</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2748890021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c500t-524d84315e4c29071dc201f97eec1b22298bfa1a4bf93d74e7c4261f8929b1493</originalsourceid><addsrcrecordid>eNp1kcFu1DAQhiMEokvhAbggSwiJi8EzceKYQyVUAUWqxAE4W45jd10l9mInEfsYvDEJuy2lEicf_m8-z-gviufA3gBj4m1mDJikDJAyiYzCg2IDvEQKnLOHxYZJXlMUUJ8UT3K-XmhRSf64OEGseVMhbopfX0c7EGP7nrY62450tvezTXsSHbnY7-JPPfhEERgZIxm3lvjgdDLjgm6tTuM74odd740efQyZxEDyjZHkKc1-1j3RoSO7ZLNN8x9uld_zEDcFs2ZPi0dO99k-O76nxfePH76dX9DLL58-n7-_pKZibKQV8q7hJVSWG5RMQGeQgZPCWgMtIsqmdRo0b50sO8GtMBxrcI1E2QKX5WlxdvDupnawnbFhTLpXu-QHnfYqaq_-TYLfqqs4q5JjySUugtdHQYo_JptHNfi83q2DjVNWwEpegeCwoi_voddxSmE5b6UENsAqsVBwoEyKOSfrbpcBptbC1aFwtRSu1sIVLDMv7l5xO3HT8AK8OgI6G927pIPx-S9Xo2BcNAuHBy4vUbiy6e6K__v9N9lcxKo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1037281057</pqid></control><display><type>article</type><title>Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Kim, Ha Won ; Jiang, Shujia ; Ashraf, Muhammad ; Haider, Khawaja Husnain</creator><creatorcontrib>Kim, Ha Won ; Jiang, Shujia ; Ashraf, Muhammad ; Haider, Khawaja Husnain</creatorcontrib><description>This study seeks to test our hypothesis that transgenic induction of miR-210 in mesenchymal stem cells (MSC) simulates the pro-survival effects of ischemic preconditioning (IPC) and that engraftment of PC MSC helps in the functional recovery of ischemic heart by miR-210 transfer to host cardiomyocytes through gap junctions. miR-210 expression in MSC was achieved by IPC or nanoparticle-based transfection of miR-210 plasmid ( miR MSC) and functional recovery of the infarcted heart of rat transplanted with PC MSC or miR MSC was evaluated. Both PC MSC and miR MSC showed higher survival under lethal anoxia as compared to non-PC MSC and scramble-transfected MSC ( Sc MSC) controls with concomitantly lower CASP8AP2 expression. Similarly, both PC MSC and miR MSC survived better and accelerated functional recovery of ischemic heart post-transplantation. To validate our hypothesis that MSC deliver miR-210 to host cardiomyocytes, in vitro co-culture between cardiomyocytes and PC MSC or miR MSC (using non-PC MSC or Sc MSC as controls) showed co-localization of miR-210 with gap-junctional connexin-43. miR-210 transfer to cardiomyocytes was blocked by heptanol pretreatment. Moreover, higher survival of cardiomyocytes co-cultured with PC MSC was observed with concomitant expression of CASP8AP2 as compared to cardiomyocytes co-cultured with non-PC MSC thus suggesting that miR-210 was translocated from MSC to protect host cardiomyocytes. Induction of miR-210 in MSC promoted their survival post-engraftment in the infarcted heart. Moreover, direct transfer of pro-survival miR-210 from miR MSC to host cardiomyocytes led to functional recovery of the ischemic heart.</description><identifier>ISSN: 0946-2716</identifier><identifier>EISSN: 1432-1440</identifier><identifier>DOI: 10.1007/s00109-012-0920-1</identifier><identifier>PMID: 22648522</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Animals ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Cardiology. Vascular system ; Cell Survival ; Cells, Cultured ; Coculture Techniques ; Coronary heart disease ; Female ; Gap Junctions - metabolism ; Gene Transfer Techniques ; General aspects ; Heart ; Heart - physiopathology ; Human Genetics ; Internal Medicine ; Male ; Medical sciences ; Mesenchymal Stem Cell Transplantation - methods ; Mesenchymal Stromal Cells - cytology ; Mesenchymal Stromal Cells - metabolism ; MicroRNAs - administration &amp; dosage ; MicroRNAs - genetics ; MicroRNAs - metabolism ; MicroRNAs - therapeutic use ; Molecular Medicine ; Myocardial Infarction - genetics ; Myocardial Infarction - physiopathology ; Myocardial Infarction - surgery ; Myocardial Infarction - therapy ; Myocytes, Cardiac - cytology ; Myocytes, Cardiac - metabolism ; Original Article ; Rats ; Rats, Inbred F344 ; Up-Regulation</subject><ispartof>Journal of molecular medicine (Berlin, Germany), 2012-09, Vol.90 (9), p.997-1010</ispartof><rights>Springer-Verlag 2012</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c500t-524d84315e4c29071dc201f97eec1b22298bfa1a4bf93d74e7c4261f8929b1493</citedby><cites>FETCH-LOGICAL-c500t-524d84315e4c29071dc201f97eec1b22298bfa1a4bf93d74e7c4261f8929b1493</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00109-012-0920-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00109-012-0920-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26270478$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22648522$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Ha Won</creatorcontrib><creatorcontrib>Jiang, Shujia</creatorcontrib><creatorcontrib>Ashraf, Muhammad</creatorcontrib><creatorcontrib>Haider, Khawaja Husnain</creatorcontrib><title>Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function</title><title>Journal of molecular medicine (Berlin, Germany)</title><addtitle>J Mol Med</addtitle><addtitle>J Mol Med (Berl)</addtitle><description>This study seeks to test our hypothesis that transgenic induction of miR-210 in mesenchymal stem cells (MSC) simulates the pro-survival effects of ischemic preconditioning (IPC) and that engraftment of PC MSC helps in the functional recovery of ischemic heart by miR-210 transfer to host cardiomyocytes through gap junctions. miR-210 expression in MSC was achieved by IPC or nanoparticle-based transfection of miR-210 plasmid ( miR MSC) and functional recovery of the infarcted heart of rat transplanted with PC MSC or miR MSC was evaluated. Both PC MSC and miR MSC showed higher survival under lethal anoxia as compared to non-PC MSC and scramble-transfected MSC ( Sc MSC) controls with concomitantly lower CASP8AP2 expression. Similarly, both PC MSC and miR MSC survived better and accelerated functional recovery of ischemic heart post-transplantation. To validate our hypothesis that MSC deliver miR-210 to host cardiomyocytes, in vitro co-culture between cardiomyocytes and PC MSC or miR MSC (using non-PC MSC or Sc MSC as controls) showed co-localization of miR-210 with gap-junctional connexin-43. miR-210 transfer to cardiomyocytes was blocked by heptanol pretreatment. Moreover, higher survival of cardiomyocytes co-cultured with PC MSC was observed with concomitant expression of CASP8AP2 as compared to cardiomyocytes co-cultured with non-PC MSC thus suggesting that miR-210 was translocated from MSC to protect host cardiomyocytes. Induction of miR-210 in MSC promoted their survival post-engraftment in the infarcted heart. Moreover, direct transfer of pro-survival miR-210 from miR MSC to host cardiomyocytes led to functional recovery of the ischemic heart.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cardiology. Vascular system</subject><subject>Cell Survival</subject><subject>Cells, Cultured</subject><subject>Coculture Techniques</subject><subject>Coronary heart disease</subject><subject>Female</subject><subject>Gap Junctions - metabolism</subject><subject>Gene Transfer Techniques</subject><subject>General aspects</subject><subject>Heart</subject><subject>Heart - physiopathology</subject><subject>Human Genetics</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mesenchymal Stem Cell Transplantation - methods</subject><subject>Mesenchymal Stromal Cells - cytology</subject><subject>Mesenchymal Stromal Cells - metabolism</subject><subject>MicroRNAs - administration &amp; dosage</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - metabolism</subject><subject>MicroRNAs - therapeutic use</subject><subject>Molecular Medicine</subject><subject>Myocardial Infarction - genetics</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Myocardial Infarction - surgery</subject><subject>Myocardial Infarction - therapy</subject><subject>Myocytes, Cardiac - cytology</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Original Article</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><subject>Up-Regulation</subject><issn>0946-2716</issn><issn>1432-1440</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kcFu1DAQhiMEokvhAbggSwiJi8EzceKYQyVUAUWqxAE4W45jd10l9mInEfsYvDEJuy2lEicf_m8-z-gviufA3gBj4m1mDJikDJAyiYzCg2IDvEQKnLOHxYZJXlMUUJ8UT3K-XmhRSf64OEGseVMhbopfX0c7EGP7nrY62450tvezTXsSHbnY7-JPPfhEERgZIxm3lvjgdDLjgm6tTuM74odd740efQyZxEDyjZHkKc1-1j3RoSO7ZLNN8x9uld_zEDcFs2ZPi0dO99k-O76nxfePH76dX9DLL58-n7-_pKZibKQV8q7hJVSWG5RMQGeQgZPCWgMtIsqmdRo0b50sO8GtMBxrcI1E2QKX5WlxdvDupnawnbFhTLpXu-QHnfYqaq_-TYLfqqs4q5JjySUugtdHQYo_JptHNfi83q2DjVNWwEpegeCwoi_voddxSmE5b6UENsAqsVBwoEyKOSfrbpcBptbC1aFwtRSu1sIVLDMv7l5xO3HT8AK8OgI6G927pIPx-S9Xo2BcNAuHBy4vUbiy6e6K__v9N9lcxKo</recordid><startdate>20120901</startdate><enddate>20120901</enddate><creator>Kim, Ha Won</creator><creator>Jiang, Shujia</creator><creator>Ashraf, Muhammad</creator><creator>Haider, Khawaja Husnain</creator><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20120901</creationdate><title>Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function</title><author>Kim, Ha Won ; Jiang, Shujia ; Ashraf, Muhammad ; Haider, Khawaja Husnain</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c500t-524d84315e4c29071dc201f97eec1b22298bfa1a4bf93d74e7c4261f8929b1493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cardiology. Vascular system</topic><topic>Cell Survival</topic><topic>Cells, Cultured</topic><topic>Coculture Techniques</topic><topic>Coronary heart disease</topic><topic>Female</topic><topic>Gap Junctions - metabolism</topic><topic>Gene Transfer Techniques</topic><topic>General aspects</topic><topic>Heart</topic><topic>Heart - physiopathology</topic><topic>Human Genetics</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mesenchymal Stem Cell Transplantation - methods</topic><topic>Mesenchymal Stromal Cells - cytology</topic><topic>Mesenchymal Stromal Cells - metabolism</topic><topic>MicroRNAs - administration &amp; dosage</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - metabolism</topic><topic>MicroRNAs - therapeutic use</topic><topic>Molecular Medicine</topic><topic>Myocardial Infarction - genetics</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Myocardial Infarction - surgery</topic><topic>Myocardial Infarction - therapy</topic><topic>Myocytes, Cardiac - cytology</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Original Article</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Ha Won</creatorcontrib><creatorcontrib>Jiang, Shujia</creatorcontrib><creatorcontrib>Ashraf, Muhammad</creatorcontrib><creatorcontrib>Haider, Khawaja Husnain</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of molecular medicine (Berlin, Germany)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Ha Won</au><au>Jiang, Shujia</au><au>Ashraf, Muhammad</au><au>Haider, Khawaja Husnain</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function</atitle><jtitle>Journal of molecular medicine (Berlin, Germany)</jtitle><stitle>J Mol Med</stitle><addtitle>J Mol Med (Berl)</addtitle><date>2012-09-01</date><risdate>2012</risdate><volume>90</volume><issue>9</issue><spage>997</spage><epage>1010</epage><pages>997-1010</pages><issn>0946-2716</issn><eissn>1432-1440</eissn><abstract>This study seeks to test our hypothesis that transgenic induction of miR-210 in mesenchymal stem cells (MSC) simulates the pro-survival effects of ischemic preconditioning (IPC) and that engraftment of PC MSC helps in the functional recovery of ischemic heart by miR-210 transfer to host cardiomyocytes through gap junctions. miR-210 expression in MSC was achieved by IPC or nanoparticle-based transfection of miR-210 plasmid ( miR MSC) and functional recovery of the infarcted heart of rat transplanted with PC MSC or miR MSC was evaluated. Both PC MSC and miR MSC showed higher survival under lethal anoxia as compared to non-PC MSC and scramble-transfected MSC ( Sc MSC) controls with concomitantly lower CASP8AP2 expression. Similarly, both PC MSC and miR MSC survived better and accelerated functional recovery of ischemic heart post-transplantation. To validate our hypothesis that MSC deliver miR-210 to host cardiomyocytes, in vitro co-culture between cardiomyocytes and PC MSC or miR MSC (using non-PC MSC or Sc MSC as controls) showed co-localization of miR-210 with gap-junctional connexin-43. miR-210 transfer to cardiomyocytes was blocked by heptanol pretreatment. Moreover, higher survival of cardiomyocytes co-cultured with PC MSC was observed with concomitant expression of CASP8AP2 as compared to cardiomyocytes co-cultured with non-PC MSC thus suggesting that miR-210 was translocated from MSC to protect host cardiomyocytes. Induction of miR-210 in MSC promoted their survival post-engraftment in the infarcted heart. Moreover, direct transfer of pro-survival miR-210 from miR MSC to host cardiomyocytes led to functional recovery of the ischemic heart.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>22648522</pmid><doi>10.1007/s00109-012-0920-1</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0946-2716
ispartof Journal of molecular medicine (Berlin, Germany), 2012-09, Vol.90 (9), p.997-1010
issn 0946-2716
1432-1440
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3423492
source MEDLINE; SpringerNature Journals
subjects Animals
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Cardiology. Vascular system
Cell Survival
Cells, Cultured
Coculture Techniques
Coronary heart disease
Female
Gap Junctions - metabolism
Gene Transfer Techniques
General aspects
Heart
Heart - physiopathology
Human Genetics
Internal Medicine
Male
Medical sciences
Mesenchymal Stem Cell Transplantation - methods
Mesenchymal Stromal Cells - cytology
Mesenchymal Stromal Cells - metabolism
MicroRNAs - administration & dosage
MicroRNAs - genetics
MicroRNAs - metabolism
MicroRNAs - therapeutic use
Molecular Medicine
Myocardial Infarction - genetics
Myocardial Infarction - physiopathology
Myocardial Infarction - surgery
Myocardial Infarction - therapy
Myocytes, Cardiac - cytology
Myocytes, Cardiac - metabolism
Original Article
Rats
Rats, Inbred F344
Up-Regulation
title Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A24%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stem%20cell-based%20delivery%20of%20Hypoxamir-210%20to%20the%20infarcted%20heart:%20implications%20on%20stem%20cell%20survival%20and%20preservation%20of%20infarcted%20heart%20function&rft.jtitle=Journal%20of%20molecular%20medicine%20(Berlin,%20Germany)&rft.au=Kim,%20Ha%20Won&rft.date=2012-09-01&rft.volume=90&rft.issue=9&rft.spage=997&rft.epage=1010&rft.pages=997-1010&rft.issn=0946-2716&rft.eissn=1432-1440&rft_id=info:doi/10.1007/s00109-012-0920-1&rft_dat=%3Cproquest_pubme%3E2748890021%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1037281057&rft_id=info:pmid/22648522&rfr_iscdi=true